RxDoctor Payments Data

Jeffrey Peretz, MD

Adult Reconstructive Orthopaedic Surgery · Atlanta, GANPI 1851551535

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Stryker at 34.7% of the total. That places this record below the midpoint for adult reconstructive orthopaedic surgery clinicians in GA, where the typical reported total is $8,375.

$1,072in general payments, 2019–2025

Across 14 payments — averaging $76.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$373
  • Zimmer Biomet$337
  • Smith+Nephew$146
  • Bioventus LLC$115
  • Medical Device Business Services, Inc.$86
  • Johnson & Johnson$15

What the payments were for

  • Food & beverage$1,072100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,072 in reported general payments places this provider in the 15th percentile of 23 adult reconstructive orthopaedic surgery providers in Georgia.

See all adult reconstructive orthopaedic surgery providers in Georgia

Medicare billing

Part B allowed, 2024
$481,460
Medicare patients
760
Services billed
5,360

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib264$4,719
XareltoRivaroxaban14$4,384
Diclofenac Sodium389$3,261
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen255$2,553
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen138$1,175
Gabapentin188$1,065
Amoxicillin314$529
Meloxicam179$460
Methylprednisolone88$374
Ondansetron Hcl91$310
Tramadol Hcl90$197
Cephalexin86$171
Clindamycin Hcl71$98
Mupirocin17$70

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$15$4,38414 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 15th percentile of 23 adult reconstructive orthopaedic surgery providers in Georgia.

Other adult reconstructive orthopaedic surgery in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →